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The number of multi drug resistant pathogens is constantly growing and novel antibiotic substances are 
desperately needed in order to at least maintain the status quo. Ribosomally synthesized antimicrobial peptides 
are not yet exploited for human applications despite an indisputable potential. Among those, lantibiotics, a class 
of posttranslationally modified and thioether-ring bearing antimicrobial peptides, show desirable properties as 
high but specific antimicrobial activity and excellent stability. 
We employ a synthetic biology approach for the generation of novel lantibiotics employing the blueprint of 
natural lantibiotics. Based on their structural and functional features, natural lantibiotics are dissected into 
modular subunits. These subunits are then shuffled to generate thousands of novel, putative active, chimeric 
lantibiotics. The lantibiotic genes are subsequently produced by combinatorial DNA de novo synthesis. 
These libraries will then be screened for molecules with high antimicrobial activity. To enable for high screening 
rates we developed a platform based on nL-sized reaction vessels (nL-reactors) that are used for peptide 
production and activity-screening in a single step and at rates of 105 variants per day. During screening, library 
cells are grown to microcolonies within nL-reactors along with a sensor strain serving as a model for a pathogen. 
Library cells secreting an active antimicrobial peptide will deactivate the sensor cells within the encircling nL-
reactor. Clearance of an nL-reactor from the sensor thus indicates the presence of a strain secreting a highly 
active peptide. We use large particle flow cytometry and fluorescently labeled cells in order to isolate promising 
candidates. 
We will present results from the screening of a peptide library containing 104 different chimeric variants derived 
from the module-shuffling of ten natural lantibiotics. Several interesting antimicrobials have been isolated, 
demonstrating for the first time the generation of new-to-nature lantibiotics by module-shuffling.  
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During the course of infection, microorganisms go through genetic and physiological changes to survive the 
selective pressures imposed by the human immune system and the antibiotic treatments. Colony morphological 
manifestations of such antimicrobial responses are fairly immediate and inexpensive to obtain experimentally, 
and can be a very useful tool in clinical decision making. Several morphotypes have already been associated to 
chronic infections and device-associated infections. For example, P. aeruginosa mucoid variants are typically 
isolated from cystic fibrosis lungs at chronic stages. These colony variants are markedly resistant to common 
antibiotics, such as gentamicin, aminoglycosides, ciprofloxacin and imipenem. Likewise, S. aureus small colony 
variants, often isolated from several chronic device-associated infections, display augmented resistance to several 
classes of antibiotics and, able to live intracellularly, and therefore surviving the action of both antibiotics and 
host immune defences. 
Therefore, the aim of this work is to introduce a novel computer-assisted microbial morphotyping platform in 
support of microbial diagnosis and further clinical decision-making. A dataset of morphotypes, extracted from 
the publicly available at MorphoCol database (http://morphocol.org), exemplifies how the platform assists in the 
manual morphological characterisation, collects data from automatic image processing tools, clusters colonies 
that show observable similar morphologies and describes the antibiotic susceptibility of the individual groups. 
Results show that key colony features, such as size, consistency and texture, can be in fact predictors of 
pathogenic potential of bacteria. Therefore, new colonies may be matched against the described groups, enabling 
the formulation of a preliminary diagnosis and therapeutics based on the previous reports.. 
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